TherapeuticsMD, Inc. (TXMD) is the 261st largest of 300 Pharmaceuticals companies by market capitalisation, at 25.12 Mn, behind CervoMed Inc. at 25.61 Mn. The table below compares all 300 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 642.97 Bn | 30.56 | 6.57 | 622.21 Bn |
| 2 | ABBV | AbbVie Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 441.24 Bn | 69.86 | 6.85 | 434.67 Bn |
| 3 | MRK | Merck & Co., Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 364.65 Bn | 115.07 | 5.48 | 357.51 Bn |
| 4 | NVS | Novartis Ag | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 266.30 Bn | 9.25 | 3.88 | 258.61 Bn |
| 5 | PFE | Pfizer Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 158.95 Bn | 36.39 | 2.50 | 147.25 Bn |
| 6 | SNY | Sanofi | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 52.43 Bn | 11.25 | 0.98 | 45.05 Bn |
| 7 | RVMD | Revolution Medicines, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 44.29 Bn | -25.05 | — | 44.29 Bn |
| 8 | INCY | Incyte Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 25.27 Bn | 15.67 | 4.34 | 20.73 Bn |
| 9 | UTHR | UNITED THERAPEUTICS Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 21.44 Bn | 16.35 | 6.80 | 18.78 Bn |
| 10 | NBIX | Neurocrine Biosciences Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.52 Bn | 22.00 | 4.60 | 15.13 Bn |
| 11 | JAZZ | Jazz Pharmaceuticals plc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.11 Bn | 16.06 | 3.28 | 13.49 Bn |
| 12 | EXEL | Exelixis, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.48 Bn | 16.83 | 5.95 | 13.64 Bn |
| 13 | CORT | Corcept Therapeutics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 12.25 Bn | 226.03 | 14.75 | 11.94 Bn |
| 14 | KYMR | Kymera Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.35 Bn | -37.89 | 108.11 | 10.66 Bn |
| 15 | AXSM | Axsome Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.83 Bn | -70.47 | 13.95 | 10.51 Bn |
| 16 | CYTK | Cytokinetics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.76 Bn | -13.31 | 144.25 | 8.60 Bn |
| 17 | NUVL | Nuvalent, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.75 Bn | -27.07 | — | 9.75 Bn |
| 18 | GPCR | Structure Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.24 Bn | -49.10 | — | 9.24 Bn |
| 19 | CRNX | Crinetics Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.99 Bn | -17.90 | 213.22 | 8.99 Bn |
| 20 | ALKS | Alkermes plc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.58 Bn | 114.59 | 4.54 | 6.92 Bn |
| 21 | TVTX | Travere Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.20 Bn | -142.66 | 10.49 | 6.08 Bn |
| 22 | BLTE | Belite Bio, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.13 Bn | 0.08 | — | 6.13 Bn |
| 23 | LQDA | Liquidia Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.11 Bn | 44.10 | 13.55 | 5.83 Bn |
| 24 | AMRN | Amarin Corp Plc\Uk | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.96 Bn | -219.55 | 31.98 | 5.64 Bn |
| 25 | ACAD | Acadia Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.76 Bn | 12.52 | 4.18 | 3.81 Bn |
| 26 | EWTX | Edgewise Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.65 Bn | -23.59 | — | 4.65 Bn |
| 27 | DFTX | Definium Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.22 Bn | -11.92 | — | 4.22 Bn |
| 28 | INDV | Indivior Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.04 Bn | 11.38 | 3.03 | 3.82 Bn |
| 29 | MANE | Veradermics, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.98 Bn | -46.18 | — | 3.98 Bn |
| 30 | CPRX | CATALYST PHARMACEUTICALS, INC. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.85 Bn | 17.94 | 6.45 | 3.09 Bn |
| 31 | ELVN | Enliven Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.83 Bn | -45.52 | — | 3.83 Bn |
| 32 | TARS | Tarsus Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.65 Bn | -77.87 | 6.03 | 3.20 Bn |
| 33 | OGN | Organon & Co. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.61 Bn | 17.26 | 0.59 | 2.47 Bn |
| 34 | NAMS | NewAmsterdam Pharma Co N.V. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.89 Bn | -11.15 | 406.27 | 2.89 Bn |
| 35 | MLYS | Mineralys Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.64 Bn | -7.55 | — | 2.64 Bn |
| 36 | TAK | Takeda Pharmaceutical Co Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.61 Bn | 4.55 | 0.06 | -3.19 Bn |
| 37 | TRVI | Trevi Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.61 Bn | -61.86 | — | 2.61 Bn |
| 38 | BEIGF | BeOne Medicines Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.48 Bn | 3.74 | 0.40 | -2.62 Bn |
| 39 | SUPN | Supernus Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.43 Bn | -28.50 | 3.08 | 2.05 Bn |
| 40 | HRMY | Harmony Biosciences Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.42 Bn | 13.55 | 2.52 | 1.61 Bn |
| 41 | NUVB | Nuvation Bio Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.29 Bn | -21.17 | 13.48 | 2.29 Bn |
| 42 | PVLA | Palvella Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.19 Bn | -41.31 | — | 1.88 Bn |
| 43 | AUPH | Aurinia Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.11 Bn | 6.72 | 6.78 | 1.67 Bn |
| 44 | ETON | Eton Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.64 Bn | 172.21 | 16.40 | 1.62 Bn |
| 45 | INVA | Innoviva, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.53 Bn | 7.78 | 2.96 | 0.95 Bn |
| 46 | LBRX | Lb Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.45 Bn | -24.01 | — | 1.45 Bn |
| 47 | XERS | Xeris Biopharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.44 Bn | -83.92 | 4.29 | 1.32 Bn |
| 48 | HROW | Harrow, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.41 Bn | -42.01 | 5.10 | 1.32 Bn |
| 49 | OPK | Opko Health, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.19 Bn | -31.30 | 2.02 | 0.89 Bn |
| 50 | OLMA | Olema Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.11 Bn | -5.42 | — | 1.11 Bn |
| 51 | KURA | Kura Oncology, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.08 Bn | -4.53 | 13.95 | 1.08 Bn |
| 52 | PCRX | Pacira BioSciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.01 Bn | 68.91 | 1.35 | 0.76 Bn |
| 53 | LXRX | Lexicon Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.95 Bn | -15.10 | 22.90 | 0.76 Bn |
| 54 | DSGN | Design Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.95 Bn | -11.71 | — | 0.74 Bn |
| 55 | SGP | SpyGlass Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.93 Bn | -48.72 | — | 0.93 Bn |
| 56 | VSTM | Verastem, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.80 Bn | -6.92 | 9.11 | 0.66 Bn |
| 57 | COLL | Collegium Pharmaceutical, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.77 Bn | 15.98 | 0.95 | 0.62 Bn |
| 58 | PHAT | Phathom Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.73 Bn | -7.48 | 3.07 | 0.55 Bn |
| 59 | ZVRA | Zevra Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.72 Bn | 12.41 | 5.31 | 0.50 Bn |
| 60 | GYRE | Gyre Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.71 Bn | -38.31 | 5.93 | 0.65 Bn |
| 61 | IVEVF | Inventiva S.A. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.69 Bn | 7.19 | 132.94 | 0.69 Bn |
| 62 | CRMD | CorMedix Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | 5.10 | 1.71 | 0.38 Bn |
| 63 | AQST | Aquestive Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | -8.16 | 11.81 | 0.54 Bn |
| 64 | MPLT | MapLight Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.62 Bn | -3.05 | — | 0.62 Bn |
| 65 | EOLS | Evolus, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.57 Bn | -16.53 | 1.79 | 0.52 Bn |
| 66 | NVCT | Nuvectis Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.55 Bn | -18.05 | — | 0.55 Bn |
| 67 | OVID | Ovid Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -15.57 | 339.28 | 0.42 Bn |
| 68 | SPRY | ARS Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.53 Bn | -2.37 | 4.49 | 0.38 Bn |
| 69 | XFOR | X4 Pharmaceuticals, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.45 Bn | -4.98 | 28.34 | 0.25 Bn |
| 70 | PALI | Palisade Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.45 Bn | -12.67 | 894.15 | 0.32 Bn |
| 71 | IKT | Inhibikase Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -6.47 | — | 0.26 Bn |
| 72 | TTRX | Turn Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -54.74 | — | 0.42 Bn |
| 73 | VTVT | vTv Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -86.08 | 11.11 | 0.41 Bn |
| 74 | SION | Sionna Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.34 Bn | -3.47 | — | 0.34 Bn |
| 75 | ACHV | Achieve Life Sciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.34 Bn | — | — | 0.34 Bn |
| 76 | VNDA | Vanda Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -1.15 | 1.46 | 0.15 Bn |
| 77 | IMRX | Immuneering Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -5.10 | — | 0.30 Bn |
| 78 | EBS | Emergent BioSolutions Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -1.68 | 0.38 | 0.16 Bn |
| 79 | FULC | Fulcrum Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -3.25 | — | 0.29 Bn |
| 80 | ZNTL | Zentalis Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.28 Bn | -1.98 | — | 0.28 Bn |
| 81 | AKBA | Akebia Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -8.83 | 1.20 | 0.11 Bn |
| 82 | CELG-RI | Bristol Myers Squibb Co | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | 0.02 | 0.00 | -10.84 Bn |
| 83 | SIGA | Siga Technologies Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | — | — | 0.07 Bn |
| 84 | TNXP | Tonix Pharmaceuticals Holding Corp. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -1.34 | 7.37 | 0.21 Bn |
| 85 | DERM | Journey Medical Corp | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -57.45 | 3.08 | 0.18 Bn |
| 86 | ACOG | Alpha Cognition Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -7.30 | 14.98 | 0.16 Bn |
| 87 | CRDL | Cardiol Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -7.71 | — | 0.20 Bn |
| 88 | NERV | Minerva Neurosciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -30.30 | — | 0.20 Bn |
| 89 | SLGL | Sol-Gel Technologies Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -18.44 | 107.71 | 0.15 Bn |
| 90 | MCUJF | Medicure Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -37.45 | 8.18 | 0.19 Bn |
| 91 | LONA | LeonaBio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.17 Bn | -1.41 | — | 0.12 Bn |
| 92 | MENS | Jyong Biotech Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.17 Bn | -46.69 | — | 0.17 Bn |
| 93 | LENZ | LENZ Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.16 Bn | -1.23 | 7.39 | 0.16 Bn |
| 94 | BMEA | Biomea Fusion, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -2.40 | — | 0.14 Bn |
| 95 | VANI | Vivani Medical, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.12 Bn | -4.27 | — | 0.10 Bn |
| 96 | AARD | Aardvark Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -1.56 | — | 0.03 Bn |
| 97 | VRCA | Verrica Pharmaceuticals Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.11 Bn | -3.42 | 3.55 | 0.10 Bn |
| 98 | CPIX | Cumberland Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -8.98 | 3.10 | 0.09 Bn |
| 99 | TENX | Tenax Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -1.46 | — | 0.09 Bn |
| 100 | CGTX | Cognition Therapeutics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -2.49 | — | 0.09 Bn |
| 101 | NTHI | Neonc Technologies Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -2.00 | — | 0.09 Bn |
| 102 | MNOV | Medicinova Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -7.56 | 99.51 | 0.09 Bn |
| 103 | PTHS | Pelthos Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | -0.76 | 1.56 | 0.06 Bn |
| 104 | RGC | Regencell Bioscience Holdings Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | — | — | 0.07 Bn |
| 105 | PMVP | PMV Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -1.19 | — | -0.01 Bn |
| 106 | PLRX | Pliant Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -0.77 | — | 0.07 Bn |
| 107 | BOLD | Boundless Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -1.00 | — | 0.06 Bn |
| 108 | VERU | Veru Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | 118.29 | — | 0.03 Bn |
| 109 | GOSS | Gossamer Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.31 | 0.99 | 0.00 Bn |
| 110 | KPTI | Karyopharm Therapeutics Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.24 | 0.32 | -0.02 Bn |
| 111 | ANVS | Annovis Bio, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.97 | — | 0.05 Bn |
| 112 | CLNN | Clene Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -1.34 | 213.66 | 0.04 Bn |
| 113 | APRE | Aprea Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -3.47 | — | 0.04 Bn |
| 114 | IXHL | Incannex Healthcare Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.85 | — | 0.04 Bn |
| 115 | GRCE | Grace Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -1.85 | — | 0.04 Bn |
| 116 | SCLX | Scilex Holding Co | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.08 | 1.16 | -0.08 Bn |
| 117 | CPHI | China Pharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -7.53 | 8.61 | 0.03 Bn |
| 118 | UG | United Guardian Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 14.43 | 2.91 | 0.02 Bn |
| 119 | ACTU | Actuate Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.55 | — | 0.03 Bn |
| 120 | NSRX | Nasus Pharma Ltd | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -5.64 | — | 0.03 Bn |
| 121 | CRVO | CervoMed Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -0.84 | 77.31 | 0.03 Bn |
| 122 | TXMD | TherapeuticsMD, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -135.76 | 7.68 | 0.02 Bn |
| 123 | BYSI | BeyondSpring Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -2.95 | — | 0.02 Bn |
| 124 | YARW | Yarrow Bioscience, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.11 | 46.15 | 0.00 Bn |
| 125 | AYTU | Aytu Biopharma, Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.74 | 0.40 | 0.00 Bn |
| 126 | ATOS | Atossa Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.73 | — | 0.02 Bn |
| 127 | BFRI | Biofrontera Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -4.30 | 0.45 | 0.02 Bn |
| 128 | ALLR | Allarity Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.67 | 808.26 | 0.02 Bn |
| 129 | MIRA | Mira Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.55 | — | 0.01 Bn |
| 130 | TVRD | Tvardi Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.68 | — | 0.02 Bn |
| 131 | KPRX | Kiora Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.46 | — | 0.02 Bn |
| 132 | CTXR | Citius Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.34 | 2.18 | 0.02 Bn |
| 133 | ANEB | Anebulo Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.64 | — | 0.01 Bn |
| 134 | INTI | Inhibitor Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -3.67 | — | 0.01 Bn |
| 135 | CALC | CalciMedica, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.33 | -8.10 | -0.01 Bn |
| 136 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.74 | — | 0.01 Bn |
| 137 | ADXN | Addex Therapeutics Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | 0.05 | — | 0.01 Bn |
| 138 | CURX | Curanex Pharmaceuticals Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.82 | — | 0.00 Bn |
| 139 | ACXP | Acurx Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.80 | — | 0.01 Bn |
| 140 | TRAW | Traws Pharma, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.34 | — | 0.00 Bn |
| 141 | PULM | Pulmatrix, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -1.40 | — | 0.01 Bn |
| 142 | PCSA | Processa Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.41 | — | 0.01 Bn |
| 143 | TCRT | Alaunos Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.94 | 1,276.64 | 0.00 Bn |
| 144 | BICX | BioCorRx Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.64 | 6.70 | 0.00 Bn |
| 145 | CVKD | Cadrenal Therapeutics, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.29 | — | 0.00 Bn |
| 146 | CASIF | CASI Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | 0.12 | 0.00 Bn |
| 147 | OGEN | Oragenics Inc | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.23 | — | 0.00 Bn |
| 148 | CANF | Can-Fite BioPharma Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.24 | 5.93 | 0.00 Bn |
| 149 | UPC | Universe Pharmaceuticals INC | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | -1,490.23 Bn |
| 150 | MTNB | Matinas BioPharma Holdings, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.16 | — | 0.00 Bn |
| 151 | ENSC | Ensysce Biosciences, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | 0.00 Bn |
| 152 | SKVI | Skinvisible, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.05 | 54.04 | 0.00 Bn |
| 153 | SPRC | SciSparc Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.05 | 0.76 | 0.00 Bn |
| 154 | NCEL | NewcelX Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.06 | — | 0.00 Bn |
| 155 | GLMD | Galmed Pharmaceuticals Ltd. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | 0.00 Bn |
| 156 | CDT | CDT Equity Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | — | 0.00 Bn |
| 157 | JAGX | Jaguar Health, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | 0.01 | -0.01 Bn |
| 158 | GCAN | Trafalgar International, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.77 | — | 0.00 Bn |
| 159 | CINGW | Cingulate Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | — | 0.00 Bn |
| 160 | SXTC | China SXT Pharmaceuticals, Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | 0.03 | -0.03 Bn |
| 161 | CMND | Clearmind Medicine Inc. | primary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | — | -0.01 Bn |
| 162 | CAT | Caterpillar Inc | secondary | I-05 | Machinery | IG-02 | 376.37 Bn | 34.71 | 5.04 | 369.66 Bn |
| 163 | MBFJF | Mitsubishi Ufj Financial Group Inc | secondary | F-02 | Banking | FG-01 | 296.69 Bn | 18.42 | 5.61 | -87.63 Bn |
| 164 | TOYOF | Toyota Motor Corp/ | secondary | D-01 | Automobiles and Components | DG-01 | 256.51 Bn | 8.85 | 0.77 | 178.52 Bn |
| 165 | IBM | International Business Machines Corp | secondary | T-43 | Cloud Computing | TG-07 | 221.54 Bn | 20.66 | 3.21 | 210.18 Bn |
| 166 | DE | Deere & Co | secondary | I-06 | Machinery | IG-02 | 182.72 Bn | 40.15 | 3.81 | 173.79 Bn |
| 167 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 181.12 Bn | -62.56 | 5.95 | 177.94 Bn |
| 168 | BBVA | Banco Bilbao Vizcaya Argentaria, S.A. | secondary | F-02 | Banking | FG-01 | 167.47 Bn | 12.92 | — | 167.47 Bn |
| 169 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 132.11 Bn | 29.99 | 10.50 | 124.26 Bn |
| 170 | HMC | Honda Motor Co Ltd | secondary | D-01 | Automobiles and Components | DG-01 | 125.73 Bn | 65.99 | 1.15 | 85.60 Bn |
| 171 | SMFG | Sumitomo Mitsui Financial Group, Inc. | secondary | F-02 | Banking | FG-01 | 101.38 Bn | 8.71 | -90.59 | 101.38 Bn |
| 172 | HPE | Hewlett Packard Enterprise Co | secondary | T-12 | Computer Hardware | TG-02 | 76.93 Bn | 28.76 | 1.84 | 70.72 Bn |
| 173 | PCAR | Paccar Inc | secondary | I-05 | Machinery | IG-02 | 63.67 Bn | 25.43 | 2.29 | 55.00 Bn |
| 174 | AJG | Arthur J. Gallagher & Co. | secondary | F-16 | Insurance | FG-04 | 63.23 Bn | 40.15 | 4.01 | 61.84 Bn |
| 175 | O | Realty Income Corp | secondary | R-06 | Property REITs | RG-01 | 56.19 Bn | 44.33 | 9.28 | 56.19 Bn |
| 176 | PSA | Public Storage | secondary | R-08 | Property REITs | RG-01 | 51.98 Bn | 28.17 | 10.63 | 51.72 Bn |
| 177 | FITB | Fifth Third Bancorp | secondary | F-01 | Banking | FG-01 | 49.31 Bn | 18.53 | 4.85 | 25.58 Bn |
| 178 | MSTR | Strategy Inc | secondary | T-23 | Business Applications | TG-03 | 47.49 Bn | -1.51 | 95.30 | 45.05 Bn |
| 179 | IX | Orix Corp | secondary | F-06 | Lending and Credit | FG-02 | 43.63 Bn | 10.88 | 1.95 | 43.63 Bn |
| 180 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.74 Bn | 61.41 | 2.47 | 39.09 Bn |
| 181 | MTB | M&T Bank Corp | secondary | F-01 | Banking | FG-01 | 34.70 Bn | 12.08 | 3.48 | 34.70 Bn |
| 182 | ALC | Alcon Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 33.94 Bn | 52.79 | 3.16 | 32.49 Bn |
| 183 | HBAN | Huntington Bancshares Inc /Md/ | secondary | F-01 | Banking | FG-01 | 33.56 Bn | 14.94 | 3.45 | 29.04 Bn |
| 184 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 30.09 Bn | -20.28 | 2,754.96 | 30.09 Bn |
| 185 | BAP | Credicorp Ltd | secondary | F-02 | Banking | FG-01 | 30.01 Bn | 3.39 | — | 30.01 Bn |
| 186 | GEHC | GE HealthCare Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 29.76 Bn | 14.51 | 1.40 | 27.65 Bn |
| 187 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 28.32 Bn | -32.35 | 24.89 | 27.16 Bn |
| 188 | RPRX | Royalty Pharma plc | secondary | F-06 | Lending and Credit | FG-02 | 26.79 Bn | 19.85 | 10.57 | 25.96 Bn |
| 189 | CINF | Cincinnati Financial Corp | secondary | F-13 | Insurance | FG-04 | 26.10 Bn | 8.04 | 1.87 | 24.20 Bn |
| 190 | SYF | Synchrony Financial | secondary | F-04 | Lending and Credit | FG-02 | 25.72 Bn | 7.49 | 1.32 | 9.52 Bn |
| 191 | RF | Regions Financial Corp | secondary | F-01 | Banking | FG-01 | 25.46 Bn | 11.84 | 3.34 | 25.46 Bn |
| 192 | FCNCA | First Citizens Bancshares Inc /De/ | secondary | F-01 | Banking | FG-01 | 24.53 Bn | 10.82 | 89.22 | 24.01 Bn |
| 193 | AER | AerCap Holdings N.V. | secondary | I-01 | Aerospace and Defense | IG-01 | 24.35 Bn | 5.76 | 2.72 | 24.35 Bn |
| 194 | KEY | Keycorp /New/ | secondary | F-01 | Banking | FG-01 | 23.23 Bn | 12.31 | 2.98 | -24.46 Bn |
| 195 | RGLD | Royal Gold Inc | secondary | F-06 | Lending and Credit | FG-02 | 22.30 Bn | 29.94 | 14.42 | 22.12 Bn |
| 196 | SNX | Td Synnex Corp | secondary | T-64 | Technology Services | TG-11 | 20.57 Bn | 18.10 | 0.29 | 19.47 Bn |
| 197 | SNA | Snap-on Inc | secondary | I-08 | Machinery | IG-02 | 19.54 Bn | 18.46 | 3.70 | 17.90 Bn |
| 198 | LEN | Lennar Corp /New/ | secondary | D-08 | Homebuilding | DG-03 | 19.29 Bn | 9.65 | 0.59 | 17.11 Bn |
| 199 | VTRS | Viatris Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.19 Bn | -46.74 | 1.30 | 18.31 Bn |
| 200 | FTAI | FTAI Aviation Ltd. | secondary | I-01 | Aerospace and Defense | IG-01 | 19.11 Bn | 40.01 | 6.14 | 18.78 Bn |
| 201 | CNH | CNH Industrial N.V. | secondary | I-06 | Machinery | IG-02 | 17.15 Bn | 65.95 | 0.94 | 15.28 Bn |
| 202 | CBSH | Commerce Bancshares Inc /Mo/ | secondary | F-01 | Banking | FG-01 | 16.67 Bn | 28.22 | 8.94 | 16.47 Bn |
| 203 | ZTO | ZTO Express (Cayman) Inc. | secondary | I-23 | Transportation | IG-05 | 16.50 Bn | 11.10 | 2.11 | 11.91 Bn |
| 204 | KIM | Kimco Realty Corp | secondary | R-03 | Property REITs | RG-01 | 15.80 Bn | 27.48 | 7.34 | 15.80 Bn |
| 205 | PNFP | Pinnacle Financial Partners, Inc. | secondary | F-01 | Banking | FG-01 | 15.00 Bn | 20.29 | 13.45 | 7.35 Bn |
| 206 | BWXT | BWX Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 14.51 Bn | 40.75 | 4.13 | 13.90 Bn |
| 207 | AIZ | Assurant, Inc. | secondary | F-13 | Insurance | FG-04 | 13.93 Bn | 13.10 | 1.04 | 11.90 Bn |
| 208 | TXT | Textron Inc | secondary | I-01 | Aerospace and Defense | IG-01 | 13.70 Bn | 14.62 | 0.90 | 12.27 Bn |
| 209 | ALLY | Ally Financial Inc. | secondary | F-02 | Banking | FG-01 | 12.87 Bn | 9.68 | 1.48 | 5.03 Bn |
| 210 | JEF | Jefferies Financial Group Inc. | secondary | F-17 | Capital Markets | FG-05 | 11.69 Bn | 14.67 | 0.99 | -3.76 Bn |
| 211 | GKOS | GLAUKOS Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.69 Bn | -67.84 | 17.44 | 10.57 Bn |
| 212 | SSB | SouthState Bank Corp | secondary | F-01 | Banking | FG-01 | 10.27 Bn | 10.81 | 35.84 | 7.89 Bn |
| 213 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.17 Bn | -26.67 | — | 9.42 Bn |
| 214 | WTFC | Wintrust Financial Corp | secondary | F-01 | Banking | FG-01 | 10.15 Bn | 11.97 | 3.54 | -62.02 Bn |
| 215 | CFR | Cullen/Frost Bankers, Inc. | secondary | F-01 | Banking | FG-01 | 10.10 Bn | 14.92 | 77.64 | 3.60 Bn |
| 216 | FCFS | FirstCash Holdings, Inc. | secondary | F-04 | Lending and Credit | FG-02 | 10.05 Bn | 25.90 | 2.44 | 9.88 Bn |
| 217 | AVB | Avalonbay Communities Inc | secondary | R-01 | Property REITs | RG-01 | 9.67 Bn | 9.28 | 3.14 | 9.87 Bn |
| 218 | AGCO | Agco Corp /De | secondary | I-06 | Machinery | IG-02 | 9.02 Bn | 18.70 | 0.87 | 8.44 Bn |
| 219 | LAD | Lithia Motors Inc | secondary | D-37 | Retail | DG-10 | 8.21 Bn | 11.40 | 0.22 | 7.84 Bn |
| 220 | VLY | Valley National Bancorp | secondary | F-01 | Banking | FG-01 | 7.62 Bn | 11.48 | 105.96 | 7.29 Bn |
| 221 | FAF | First American Financial Corp | secondary | F-14 | Insurance | FG-04 | 7.32 Bn | 9.79 | 0.92 | 4.20 Bn |
| 222 | TEX | Terex Corp | secondary | I-05 | Machinery | IG-02 | 7.01 Bn | 47.06 | 1.05 | 6.61 Bn |
| 223 | OR | OR Royalties Inc. | secondary | F-06 | Lending and Credit | FG-02 | 7.00 Bn | 18.51 | 19.29 | 6.92 Bn |
| 224 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.43 Bn | -39.47 | 1.21 | 6.06 Bn |
| 225 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.30 Bn | -703.30 | 4,524.98 | 6.30 Bn |
| 226 | GATX | Gatx Corp | secondary | I-11 | Machinery | IG-02 | 6.25 Bn | 26.60 | 3.05 | 6.25 Bn |
| 227 | HOMB | Home Bancshares Inc | secondary | F-01 | Banking | FG-01 | 5.97 Bn | 12.45 | 128.98 | 4.91 Bn |
| 228 | STWD | Starwood Property Trust, Inc. | secondary | F-08 | Lending and Credit | FG-02 | 5.81 Bn | 21.94 | 2.89 | 3.64 Bn |
| 229 | RUSHA | Rush Enterprises Inc \Tx\ | secondary | I-31 | Distribution and Rental | IG-07 | 5.75 Bn | 21.51 | 0.79 | 5.48 Bn |
| 230 | ASB | Associated Banc-Corp | secondary | F-01 | Banking | FG-01 | 5.69 Bn | 11.53 | 112.20 | 4.74 Bn |
| 231 | AUB | Atlantic Union Bankshares Corp | secondary | F-01 | Banking | FG-01 | 5.61 Bn | 11.80 | 3.64 | 4.52 Bn |
| 232 | ENVA | Enova International, Inc. | secondary | F-04 | Lending and Credit | FG-02 | 5.57 Bn | 15.67 | 1.62 | 5.45 Bn |
| 233 | RITM | Rithm Capital Corp. | secondary | F-08 | Lending and Credit | FG-02 | 5.52 Bn | 16.49 | 1.09 | 5.52 Bn |
| 234 | AMRX | Amneal Pharmaceuticals, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.51 Bn | 25.60 | 1.77 | 5.38 Bn |
| 235 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.01 Bn | -17.45 | — | 5.01 Bn |
| 236 | HASI | HA Sustainable Infrastructure Capital, Inc. | secondary | F-11 | Asset and Wealth Management | FG-03 | 4.90 Bn | 55.06 | 10.58 | 4.65 Bn |
| 237 | FMCQF | Fresenius Medical Care AG | secondary | H-14 | Healthcare Providers | HG-04 | 4.79 Bn | 4.57 | 0.17 | 4.09 Bn |
| 238 | SKY | Champion Homes, Inc. | secondary | D-09 | Homebuilding | DG-03 | 4.66 Bn | — | — | 4.02 Bn |
| 239 | MARA | MARA Holdings, Inc. | secondary | T-59 | Fintech | TG-09 | 4.48 Bn | -1.30 | 5.57 | 4.04 Bn |
| 240 | UCB | United Community Banks Inc | secondary | F-01 | Banking | FG-01 | 4.20 Bn | 11.33 | 3.78 | 3.65 Bn |
| 241 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.04 Bn | -7.90 | 1,120.56 | 4.04 Bn |
| 242 | OPLN | OPENLANE, Inc. | secondary | T-51 | Internet Platforms | TG-08 | 4.02 Bn | -47.20 | 1.94 | 3.83 Bn |
| 243 | ABG | Asbury Automotive Group Inc | secondary | D-37 | Retail | DG-10 | 3.84 Bn | 7.54 | 0.21 | 3.80 Bn |
| 244 | SKYW | Skywest Inc | secondary | I-18 | Transportation | IG-05 | 3.77 Bn | 9.19 | 0.90 | 3.17 Bn |
| 245 | RNST | Renasant Corp | secondary | F-01 | Banking | FG-01 | 3.70 Bn | 11.77 | 3.37 | 2.82 Bn |
| 246 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.56 Bn | -7.75 | 30.47 | 2.86 Bn |
| 247 | SII | Sprott Inc. | secondary | F-09 | Asset and Wealth Management | FG-03 | 3.39 Bn | 32.28 | 8.47 | 3.20 Bn |
| 248 | FFBC | First Financial Bancorp /Oh/ | secondary | F-01 | Banking | FG-01 | 3.34 Bn | 11.73 | 3.32 | 3.34 Bn |
| 249 | BKU | BankUnited, Inc. | secondary | F-01 | Banking | FG-01 | 3.28 Bn | 12.00 | 138.53 | 2.92 Bn |
| 250 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.99 Bn | -11.06 | 593.06 | 2.47 Bn |
| 251 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.92 Bn | -8.55 | 79.42 | 2.48 Bn |
| 252 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.83 Bn | -15.06 | 6.30 | 2.13 Bn |
| 253 | HOG | Harley-Davidson, Inc. | secondary | D-04 | Automobiles and Components | DG-01 | 2.81 Bn | 14.37 | 0.66 | 0.92 Bn |
| 254 | CURLF | Curaleaf Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 2.69 Bn | -22.73 | 2.06 | 2.60 Bn |
| 255 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.67 Bn | -82.12 | — | 2.67 Bn |
| 256 | FBNC | First Bancorp /Nc/ | secondary | F-01 | Banking | FG-01 | 2.63 Bn | 19.74 | 5.28 | 2.08 Bn |
| 257 | BBT | Beacon Financial Corp | secondary | F-01 | Banking | FG-01 | 2.60 Bn | 16.26 | 81.95 | 1.38 Bn |
| 258 | AGM | Federal Agricultural Mortgage Corp | secondary | F-05 | Lending and Credit | FG-02 | 2.47 Bn | 12.32 | 5.53 | 1.43 Bn |
| 259 | MBIN | Merchants Bancorp | secondary | F-01 | Banking | FG-01 | 2.41 Bn | 10.55 | 3.38 | 1.57 Bn |
| 260 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.38 Bn | -2.18 | 0.22 | 0.54 Bn |
| 261 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.32 Bn | -6.04 | 4.35 | 1.97 Bn |
| 262 | PBI | Pitney Bowes Inc /De/ | secondary | I-30 | Business Services | IG-06 | 2.32 Bn | 15.26 | 1.66 | 2.04 Bn |
| 263 | PLUS | Eplus Inc | secondary | T-64 | Technology Services | TG-11 | 2.30 Bn | 16.10 | 0.91 | 1.85 Bn |
| 264 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.26 Bn | -3.84 | — | 1.99 Bn |
| 265 | TRN | Trinity Industries Inc | secondary | I-11 | Machinery | IG-02 | 2.23 Bn | 6.32 | 1.09 | 2.08 Bn |
| 266 | LTC | Ltc Properties Inc | secondary | R-07 | Property REITs | RG-01 | 2.17 Bn | 16.08 | 6.23 | 2.17 Bn |
| 267 | ECPG | Encore Capital Group Inc | secondary | F-06 | Lending and Credit | FG-02 | 2.11 Bn | 7.00 | 1.11 | 1.93 Bn |
| 268 | BLX | Bladex, Inc. | secondary | F-01 | Banking | FG-01 | 2.06 Bn | 1.50 | 5.84 | 2.05 Bn |
| 269 | SRCE | 1St Source Corp | secondary | F-01 | Banking | FG-01 | 2.06 Bn | 12.04 | 69.41 | 2.06 Bn |
| 270 | TBBK | Bancorp, Inc. | secondary | F-02 | Banking | FG-01 | 2.05 Bn | 9.19 | 13.64 | 1.97 Bn |
| 271 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.04 Bn | -4.91 | 2,041.68 | 2.04 Bn |
| 272 | CMRE | Costamare Inc. | secondary | I-21 | Transportation | IG-05 | 1.80 Bn | 5.65 | 2.09 | 1.43 Bn |
| 273 | SMA | SmartStop Self Storage REIT, Inc. | secondary | R-08 | Property REITs | RG-01 | 1.77 Bn | 61.40 | 5.78 | 1.73 Bn |
| 274 | BY | Byline Bancorp, Inc. | secondary | F-01 | Banking | FG-01 | 1.69 Bn | 11.30 | 3.65 | 1.47 Bn |
| 275 | QCRH | Qcr Holdings Inc | secondary | F-01 | Banking | FG-01 | 1.68 Bn | 20.05 | 10.54 | 0.85 Bn |
| 276 | CASH | Pathward Financial, Inc. | secondary | F-02 | Banking | FG-01 | 1.67 Bn | 9.43 | 11.12 | 1.52 Bn |
| 277 | TRIN | Trinity Capital Inc. | secondary | F-07 | Lending and Credit | FG-02 | 1.63 Bn | 9.57 | 4.85 | 1.61 Bn |
| 278 | IIPR | Innovative Industrial Properties Inc | secondary | R-04 | Property REITs | RG-01 | 1.62 Bn | 12.46 | 6.14 | 1.62 Bn |
| 279 | BC-PC | Brunswick Corp | secondary | D-04 | Automobiles and Components | DG-01 | 1.59 Bn | -40.68 | 0.28 | 1.28 Bn |
| 280 | TFIN | Triumph Financial, Inc. | secondary | F-01 | Banking | FG-01 | 1.57 Bn | 44.39 | 27.58 | 0.67 Bn |
| 281 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.54 Bn | -9.11 | 20.12 | 1.26 Bn |
| 282 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.50 Bn | -3.24 | 2.09 | 1.21 Bn |
| 283 | ANIP | Ani Pharmaceuticals Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.49 Bn | 13.83 | 1.53 | 1.13 Bn |
| 284 | CSWC | Capital Southwest Corp | secondary | F-07 | Lending and Credit | FG-02 | 1.47 Bn | 21.12 | 6.18 | 1.41 Bn |
| 285 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.42 Bn | -8.65 | — | 1.42 Bn |
| 286 | TRTN-PA | Triton International Ltd | secondary | I-11 | Machinery | IG-02 | 1.42 Bn | -2.77 | 19.65 | 1.42 Bn |
| 287 | ATLC | Atlanticus Holdings Corp | secondary | F-06 | Lending and Credit | FG-02 | 1.41 Bn | 9.75 | 0.53 | 0.86 Bn |
| 288 | CNF | CNFinance Holdings Ltd. | secondary | F-05 | Lending and Credit | FG-02 | 1.40 Bn | -27.01 | 27.62 | 1.40 Bn |
| 289 | TMP | Tompkins Financial Corp | secondary | F-01 | Banking | FG-01 | 1.39 Bn | 7.92 | 3.05 | 1.39 Bn |
| 290 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.39 Bn | 81.23 | 36.08 | 1.39 Bn |
| 291 | PEBO | Peoples Bancorp Inc | secondary | F-01 | Banking | FG-01 | 1.38 Bn | -40.60 | 54.52 | 1.20 Bn |
| 292 | GOLD | Gold.com, Inc. | secondary | D-36 | Retail | DG-10 | 1.35 Bn | 16.35 | 0.06 | 0.77 Bn |
| 293 | GBX | Greenbrier Companies Inc | secondary | I-11 | Machinery | IG-02 | 1.32 Bn | 14.65 | 0.50 | 1.05 Bn |
| 294 | MSDL | Morgan Stanley Direct Lending Fund | secondary | F-07 | Lending and Credit | FG-02 | 1.25 Bn | 35.97 | 3.35 | 1.17 Bn |
| 295 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.23 Bn | -25.65 | — | 1.01 Bn |
| 296 | WLFC | Willis Lease Finance Corp | secondary | I-01 | Aerospace and Defense | IG-01 | 1.20 Bn | 13.94 | 1.57 | 1.20 Bn |
| 297 | JCAP | Jefferson Capital, Inc. / DE | secondary | F-06 | Lending and Credit | FG-02 | 1.20 Bn | 8.20 | 1.88 | 1.18 Bn |
| 298 | OCSL | Oaktree Specialty Lending Corp | secondary | F-07 | Lending and Credit | FG-02 | 1.12 Bn | 20.61 | 2.46 | 1.08 Bn |
| 299 | UPBD | Upbound Group, Inc. | secondary | F-06 | Lending and Credit | FG-02 | 1.06 Bn | 11.70 | 0.22 | 0.95 Bn |
| 300 | LU | Lufax Holding Ltd | secondary | F-06 | Lending and Credit | FG-02 | 1.05 Bn | -2.07 | 0.29 | -1.58 Bn |